Clinical Trials Directory

Trials / Sponsors / MC2 Therapeutics

MC2 Therapeutics

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedEfficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)
Vulvar Lichen Sclerosus
Phase 22023-10-11
CompletedThe MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
Chronic Kidney Disease-associated Pruritus
Phase 22022-07-01
CompletedEvaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream
Phototoxicity
Phase 12019-02-27
CompletedEvaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream
Photoallergy
Phase 12019-02-13
TerminatedA Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects
Psoriasis Vulgaris
Phase 22018-12-27
CompletedThis Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group
Psoriasis Vulgaris
Phase 32018-12-12
CompletedEvaluation of the Vasoconstriction Properties of MC2-01 Cream
Vasoconstriction
Phase 12018-11-05
CompletedA Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream
Psoriasis Vulgaris
Phase 22018-02-08
CompletedA Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream
Psoriasis Vulgaris
Phase 32017-10-03